Jiejie Hao

Title: Jiejie Hao: Innovator in β-Glucan Composition

Introduction

Jiejie Hao is a notable inventor based in Shandong, China. He has made significant contributions to the field of immunology through his innovative work on β-glucan compositions. His research focuses on developing effective treatments for immune-related diseases.

Latest Patents

Jiejie Hao holds a patent for a β-glucan composition and its uses. This composition is specifically designed for improving or treating immune-related diseases. The β-glucan features a unique structure with β-1,3 and β-1,6 glucosidic bonds, and a molecular weight ranging from 1-50 kDa. The composition boasts several advantages, including controllable mass, abundant sources, simple preparation processes, high product purity, and strong biological activity. It has demonstrated better antitumor activity and holds potential as a safe and effective novel drug for treating immune-related diseases and combating tumors.

Career Highlights

Throughout his career, Jiejie Hao has worked with various organizations, including Qingdao Conson Pharmaceutical Co., Ltd. and Marine Biomedical Research Institute of Qingdao Co., Ltd. His experience in these companies has contributed to his expertise in the field of pharmaceutical research and development.

Collaborations

Jiejie Hao has collaborated with notable colleagues, including Youjing Lv and Chenyang Zhao. Their combined efforts have further advanced the research and application of β-glucan compositions in medical science.

Conclusion

Jiejie Hao's innovative work in the development of β-glucan compositions highlights his commitment to improving treatments for immune-related diseases. His contributions to the field are significant and pave the way for future advancements in immunology.